No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
887 |
4. Check minimum number of eventsNone |
887 |
5. Include endpointsNone |
887 |
6. Filter based on genotype QC (FinnGen only) |
887 |
Control definitions (FinnGen only)
- Control exclude
- F5_PSYCHDEV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F80-F89
- Name in latin
- Perturbationes progressus specificae mixtae
Similar endpoints
↥List of similar endpoints to
Mixed specific developmental disorders
based on the number of shared cases.
Similar with more cases:
- Disorders of psychological development
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 32334 | 9898 | 22428 |
| Only index persons | 24048 | 7389 | 16659 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.52 | 0.28 | 0.63 |
| Only index persons | 0.52 | 0.27 | 0.64 |
| Median age at first event (years) | |||
| Whole population | 5.94 | 6.11 | 5.86 |
| Only index persons | 6.45 | 6.68 | 6.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 887 | 377 | 510 |
| Unadjusted period prevalence (%) | 0.18 | 0.13 | 0.22 |
| Median age at first event (years) | 6.63 | 7.37 | 6.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 727
- Matched controls
- 7031
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F83
ICD-10 Finland
Mixed specific developmental disorders
+∞
323.0
728
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
237.6
121.2
123
6
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
124.7
119.8
128
12
XA800
NOMESCO Finland
Neuropsychological investigation
18.8
113.8
183
123
R62.0
ICD-10 Finland
Delayed milestone
24.1
107.6
158
80
F80.1
ICD-10 Finland
Expressive language disorder
279.2
99.1
100
*
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
1000.7
93.9
91
*
Z2445
NOMESCO Finland
Psychologist
7.5
77.9
208
358
F80.2
ICD-10 Finland
Receptive language disorder
268.6
73.9
75
*
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
186.6
67.4
70
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
17.8
62.7
101
63
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.4
62.0
184
355
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.9
58.5
229
607
N03AG01
ATC
valproic acid; systemic, rectal
8.8
56.4
129
168
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
287.6
54.2
55
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
194.9
54.0
56
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.9
53.1
165
332
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.6
52.6
132
198
N05AX08
ATC
risperidone; systemic
7.2
51.7
136
218
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
22.2
46.7
69
33
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.6
46.4
149
308
N06BA04
ATC
methylphenidate; oral
6.3
45.2
131
238
Z2446
NOMESCO Finland
Social worker
4.3
44.5
189
525
Z3226
NOMESCO Finland
Physiotherapist
3.7
43.3
231
784
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
6.9
43.3
115
185
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
42.9
227
762
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.1
39.4
116
213
Z50.5
ICD-10 Finland
Speech therapy
8.8
38.8
87
107
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
38.2
205
686
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.7
38.0
103
169
R4120
NOMESCO Finland
Occupational therapy
7.5
36.8
91
131
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
102.0
36.6
40
*
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
39.4
36.4
46
12
F84.5
ICD-10 Finland
Asperger syndrome
128.8
35.5
38
*
Z31.5
ICD-10 Finland
Genetic counselling
5.5
35.0
111
222
N05BA01
ATC
diazepam; systemic, rectal
5.2
33.5
113
242
183
Kela drug reimbursment
Lamotrigin and topiramate
15.9
33.3
55
36
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
118.2
32.5
35
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.2
32.4
75
97
N05AX12
ATC
aripiprazole; systemic
5.6
32.1
100
195
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
31.9
222
886
N05BA09
ATC
clobazam; oral
12.6
30.8
56
46
R1260
NOMESCO Finland
Evaluation of communicative skills
20.5
30.7
46
23
RL140
NOMESCO Finland
NA
22.0
30.7
45
21
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.6
30.6
94
180
F84.0
ICD-10 Finland
Childhood autism
+∞
30.0
29
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.3
29.5
63
71
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
14.7
29.5
50
35
N03AX14
ATC
levetiracetam; systemic
8.7
28.9
64
77
N03AX09
ATC
lamotrigine; oral
5.4
28.5
91
182
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
27.9
27
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.1
27.7
116
307
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.4
27.5
148
484
N03AF02
ATC
oxcarbazepine; oral
7.0
26.9
69
104
P85
ICPC
Mental retardation
20.4
26.7
40
20
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.2
26.3
108
280
RT150
NOMESCO Finland
NA
15.7
26.1
43
28
EBA15
NOMESCO Finland
Extraction of large number of teeth
8.1
25.5
59
76
N05AH03
ATC
olanzapine; systemic
4.6
24.9
92
215
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
24.9
278
1427
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
24.7
110
307
N05AH04
ATC
quetiapine; oral
2.9
24.4
172
676
RL130
NOMESCO Finland
NA
16.5
24.2
39
24
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
24.2
165
635
RT160
NOMESCO Finland
NA
18.8
24.1
37
20
Z3231
NOMESCO Finland
Registered nurse
2.3
23.0
284
1517
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
12.6
22.8
41
33
R4110
NOMESCO Finland
Physiotherapy
2.7
22.8
192
835
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.4
22.1
69
134
N03AX11
ATC
topiramate; oral
8.1
22.0
50
63
N05CD08
ATC
midazolam; nasal, systemic
6.9
21.9
56
84
H50.31
ICD-10 Finland
Intermittent exotropia
8.2
21.7
49
61
ZXE00
NOMESCO Finland
One hour or less
2.2
21.4
311
1777
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
23.2
21.0
30
13
WZB00
SPAT
NA
0.1
20.7
11
760
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
20.5
236
1202
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.6
20.3
74
170
RT490
NOMESCO Finland
NA
27.0
19.8
27
10
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
19.7
111
371
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.6
19.5
71
163
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.3
19.5
104
334
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
19.0
231
1201
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
7.5
18.9
45
61
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
54.7
18.7
22
*
Z2221
NOMESCO Finland
Medical doctor
2.3
18.7
212
1063
F89
ICD-10 Finland
Unspecified disorder of psychological development
+∞
18.6
18
*
R1250
NOMESCO Finland
Evaluation of functional capability
11.8
18.5
34
29
P24
ICPC
Specific learning problem
5.4
18.2
56
107
R4130
NOMESCO Finland
Speech therapy
8.5
18.2
40
48
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
10.1
18.1
36
36
K03.66
ICD-10 Finland
Tooth plaque
2.7
17.9
136
549
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
17.7
94
300
A28
ICPC
Limited function/disability NOS
4.2
17.1
67
166
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.1
16.7
33
33
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
62.7
16.5
19
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.3
16.4
86
272
F70
ICD-10 Finland
Mild mental retardation
89.0
16.4
18
*
H52.0
ICD-10 Finland
Hypermetropia
4.6
16.2
57
127
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
16.2
99
347
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.8
16.0
70
191
ZY010
NOMESCO Finland
Hospital outpatient
2.9
16.0
107
400
H01AC01
ATC
somatropin; parenteral
5.4
15.9
48
90
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
29.8
15.9
21
7
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
24.3
15.8
22
9
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
20.8
15.8
23
11
N03AX18
ATC
lacosamide; systemic
13.5
15.7
27
20
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.9
15.7
67
179
RS222
NOMESCO Finland
NA
7.5
15.7
37
50
RT420
NOMESCO Finland
NA
33.0
15.5
20
6
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
11.2
15.5
29
26
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.4
15.3
57
134
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.2
15.2
48
95
SPAT1234
SPAT
Support of social functional capacity
6.6
15.1
39
60
N05AH02
ATC
clozapine; systemic
6.1
15.0
41
68
WX002
NOMESCO Finland
Sedation and analgesia
2.9
15.0
99
366
H81
ICPC
Excessive ear wax
3.3
14.8
78
248
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
3.1
14.5
83
279
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
+∞
14.4
14
*
N05AA02
ATC
levomepromazine; systemic
6.8
14.4
36
53
R5140
NOMESCO Finland
Monitoring the use of the aid
5.3
14.4
44
84
F88
ICD-10 Finland
Other disorders of psychological development
79.0
14.4
16
*
H52.2
ICD-10 Finland
Astigmatism
4.6
14.4
50
110
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.7
14.3
102
396
IGV01
NOMESCO Finland
Psychiatric network contact
5.9
14.3
40
69
SPAT1229
SPAT
Assessment of need for aid
7.3
14.2
34
47
F81.0
ICD-10 Finland
Specific reading disorder
16.8
14.1
22
13
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
14.0
157
770
R5599
NOMESCO Finland
Other rehabilitation service
5.9
13.4
37
63
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.4
13.3
65
195
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
13.2
77
263
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
9.0
13.0
27
30
XX4AW
NOMESCO Finland
NA
6.3
13.0
34
54
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
12.9
56
153
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.3
12.7
26
28
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.6
12.7
44
97
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
12.7
72
241
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
12.6
130
613
IEV99
NOMESCO Finland
Other psychiatric network intervention
6.0
12.5
34
57
G91.1
ICD-10 Finland
Obstructive hydrocephalus
31.5
12.4
16
5
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
4.3
12.4
46
109
DFF20
NOMESCO Finland
Audiometry for children
6.3
12.2
32
51
F20.9
ICD-10 Finland
Schizophrenia, unspecified
6.3
12.2
32
51
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.7
12.2
54
150
RS220
NOMESCO Finland
NA
5.4
12.1
36
67
T82
ICPC
Obesity
4.8
12.1
40
84
R62.9
ICD-10 Finland
Lack of expected normal physiological development, unspecified
36.9
12.0
15
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.0
11.8
71
246
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.7
11.7
52
145
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.8
11.7
244
1515
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.4
11.6
105
462
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.1
11.6
45
111
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
10.4
11.5
22
21
H50.0
ICD-10 Finland
Convergent concomitant strabismus
5.6
11.5
33
59
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.5
356
2498
N06AB04
ATC
citalopram; systemic
2.8
11.5
75
275
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
63.8
11.5
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
11.5
197
1143
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
11.4
90
367
N03AX22
ATC
perampanel; oral
18.6
11.4
17
9
N03AX15
ATC
zonisamide; oral
22.5
11.4
16
7
Z02.7
ICD-10 Finland
Issue of medical certificate
3.4
11.4
55
164
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
11.3
11
*
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
11.3
11
*
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
117.7
11.3
12
*
L28
ICPC
Limited function/disability (L)
3.1
11.3
64
214
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
11.1
280
1841
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
34.4
11.1
14
*
WX110
NOMESCO Finland
Local anesthesy
1.8
11.1
522
4137
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.9
11.0
35
71
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.8
10.9
71
259
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.7
10.9
47
128
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
13.7
10.8
18
13
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
10.7
117
563
N03AG04
ATC
vigabatrin; oral
11.7
10.6
19
16
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
10.6
129
653
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.7
10.6
74
284
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
6.4
10.6
27
42
P99
ICPC
Psychological disorders other
4.3
10.5
38
88
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
10.5
152
823
G47.3
ICD-10 Finland
Sleep apnoea
3.0
10.5
60
202
H50.30
ICD-10 Finland
Intermittent esotropy
6.3
10.4
27
43
KAY40
NOMESCO Finland
NA
0.1
10.4
*
352
G40.10
ICD-10 Finland
Simple partial seizures
9.9
10.3
20
20
RL720
NOMESCO Finland
NA
+∞
10.3
10
*
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
10.3
10
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
6.5
10.3
26
40
T90
ICPC
Diabetes non-insulin dependent
4.2
10.2
38
91
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
5.8
10.2
28
48
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
15.8
10.2
16
10
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
3.0
10.1
59
203
101
Kela drug reimbursment
Anterior pituitary hypofunction
5.7
10.0
28
49
P22
ICPC
Child behaviour symptom/complaint
3.4
10.0
48
143
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
6.5
10.0
25
38
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.3
9.9
101
469
F80.0
ICD-10 Finland
Specific speech articulation disorder
7.8
9.9
22
28
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
5.6
9.9
28
50
P29
ICPC
Psychological sympt/compl other
2.4
9.9
84
359
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
39.3
9.8
12
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
9.0
9.8
20
22
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
9.8
143
777
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
16.4
9.7
15
9
C03CA01
ATC
furosemide; systemic
3.5
9.7
44
126
RS140
NOMESCO Finland
NA
8.0
9.6
21
26
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.3
9.6
18
590
602
Kela drug reimbursment
Children's severe malnutrition
3.6
9.5
42
117
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.9
9.5
158
896
UDC00
NOMESCO Finland
Ear microscopy
2.5
9.5
74
302
RT190
NOMESCO Finland
NA
13.1
9.5
16
12
XCK00
NOMESCO Finland
Perimetry
4.6
9.5
32
70
N05BA06
ATC
lorazepam; systemic, sublingual
5.5
9.4
27
49
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
4.8
9.4
30
62
Z72.8
ICD-10 Finland
Other problems related to lifestyle
8.9
9.3
19
21
N29
ICPC
Neurological sympt/complt other
7.0
9.3
22
31
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
9.3
61
223
AA1AD
NOMESCO Finland
CT of head and brain
2.5
9.3
74
303
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
9.3
9
*
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
17.2
9.2
14
8
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
5.3
9.1
27
51
EBA00
NOMESCO Finland
Extraction of tooth
1.6
9.1
297
2071
N06BA09
ATC
atomoxetine; oral
8.5
9.1
19
22
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.4
9.1
32
73
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
9.1
203
1271
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
9.1
41
117
R11
ICD-10 Finland
Nausea and vomiting
2.3
9.0
83
367
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.5
9.0
41
118
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
8.9
59
1133
F80
ICD-10 Finland
Specific developmental disorders of speech and language
35.9
8.9
11
*
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
15.3
8.9
14
9
RS312
NOMESCO Finland
NA
15.3
8.9
14
9
SPAT1262
SPAT
Handing over of treatment supplies
2.5
8.9
70
288
A10BA02
ATC
metformin; oral
3.2
8.9
46
146
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
6.2
8.9
23
37
G40.89
ICD-10 Finland
Other epilepsy
8.9
8.8
18
20
ZXA00
NOMESCO Finland
Right side
2.2
8.8
96
461
N03AF01
ATC
carbamazepine; oral, rectal
7.3
8.7
20
27
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.8
8.7
56
205
OAB43
SPAT
NA
0.4
8.7
31
754
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
12.3
8.7
15
12
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.4
8.6
30
68
K02.1
ICD-10 Finland
Caries of dentine
1.6
8.5
451
3544
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.6
8.5
62
244
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.5
402
3071
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.5
8.5
21
32
ZXA05
NOMESCO Finland
Left side
2.2
8.4
91
434
UJD02
NOMESCO Finland
Gastroscopy
5.0
8.4
26
52
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.1
8.4
18
22
181
Kela drug reimbursment
Retigabine and vigabatrin
9.8
8.4
16
16
H50.1
ICD-10 Finland
Divergent concomitant strabismus
6.8
8.4
20
29
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.7
8.3
57
217
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.2
8.3
43
137
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
8.3
43
137
N06AB03
ATC
fluoxetine; oral
2.4
8.3
72
312
KAY20
NOMESCO Finland
NA
0.1
8.3
*
252
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
+∞
8.2
8
*
SPAT1281
SPAT
Other administrative function
2.3
8.2
78
350
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
6.6
8.2
20
30
P98
ICPC
Psychosis NOS/other
8.4
8.1
17
20
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
8.1
118
635
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
5.0
8.1
25
50
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.9
8.1
32
82
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
8.1
51
184
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
5.4
8.1
23
42
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
6.9
8.1
19
27
F91.3
ICD-10 Finland
Oppositional defiant disorder
14.2
8.1
13
9
K05.18
ICD-10 Finland
Chronic gingivitis
2.8
8.0
50
178
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
8.0
182
1142
SPAT1395
SPAT
Health check-up of persons outside student and working life
5.9
7.9
21
35
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
7.9
58
229
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
16.8
7.9
12
7
H47.2
ICD-10 Finland
Optic atrophy
16.8
7.9
12
7
SPAT1167
SPAT
Insertion of urinary catheter
21.5
7.9
11
5
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.0
7.8
45
153
H66.9
ICD-10 Finland
Otitis media, unspecified
1.8
7.8
155
931
N03AE01
ATC
clonazepam; systemic
4.5
7.8
26
57
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
7.7
119
656
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
7.7
65
276
-
ICD-10 Finland
NA
12.8
7.7
13
10
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.1
7.7
40
128
E11
ICD-10 Finland
Type 2 diabetes mellitus
6.0
7.7
20
33
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
6.0
7.7
20
33
SPAT1216
SPAT
Assessment of functional ability
2.4
7.7
62
259
P07.2
ICD-10 Finland
Extreme immaturity
43.9
7.6
9
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.6
7.6
25
54
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.0
7.6
43
144
C01AA05
ATC
digoxin; systemic
14.7
7.6
12
8
A06AD11
ATC
lactulose; oral
2.6
7.5
55
217
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.5
169
1053
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.9
7.5
44
153
N03AF03
ATC
rufinamide; oral
17.9
7.5
11
6
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
17.9
7.5
11
6
ZXD20
NOMESCO Finland
Day surgery
2.2
7.5
78
368
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.5
7.4
33
94
RF120
NOMESCO Finland
NA
7.9
7.4
16
20
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
9.8
7.4
14
14
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
7.4
65
282
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
6.0
7.4
19
31
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
7.3
58
240
N05BE01
ATC
buspirone; oral
5.6
7.3
20
35
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
7.3
68
306
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
7.3
95
491
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
7.3
120
675
ZXA10
NOMESCO Finland
Bilateral
1.9
7.3
108
587
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.3
7.3
67
298
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.9
7.2
120
677
RS314
NOMESCO Finland
NA
13.1
7.2
12
9
RS311
NOMESCO Finland
NA
13.1
7.2
12
9
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.6
7.2
31
86
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.2
7.2
26
62
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
5.2
7.2
21
40
RS211
NOMESCO Finland
NA
5.5
7.2
20
36
XKD00
NOMESCO Finland
Uroflowmetry
2.8
7.2
43
152
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.2
102
546
N03AD01
ATC
ethosuximide; oral
10.6
7.2
13
12
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.7
7.1
49
186
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
9.2
7.1
14
15
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
7.1
96
503
Z61.8
ICD-10 Finland
Other negative life events in childhood
6.7
7.1
17
25
K07.24
ICD-10 Finland
Open bite
3.3
7.0
34
104
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
19.5
7.0
10
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
7.0
48
183
F22.0
ICD-10 Finland
Delusional disorder
7.8
6.9
15
19
Z03
ICPC
Housing/neighbourhood problem
11.8
6.9
12
10
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
11.8
6.9
12
10
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.0
6.9
87
445
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
6.9
52
210
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.9
198
1314
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
5.2
6.9
20
38
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
9.8
6.9
13
13
M41.4
ICD-10 Finland
Neuromuscular scoliosis
9.8
6.9
13
13
N05AF03
ATC
chlorprothixene; systemic
5.5
6.9
19
34
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.4
6.9
31
90
F93.89
ICD-10 Finland
Other childhood emotional disorders
2.9
6.8
40
139
H02AB09
ATC
hydrocortisone; systemic
2.7
6.8
44
162
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.1
6.8
35
112
SDA02
NOMESCO Finland
Parodonthologic therapy
1.6
6.8
231
1600
N05BA04
ATC
oxazepam; oral
1.9
6.8
97
518
F28
ICD-10 Finland
Other nonorganic psychotic disorders
13.5
6.8
11
8
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.8
6.7
27
71
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.4
6.7
15
20
N05AD01
ATC
haloperidol; systemic
5.7
6.7
18
31
SPAT1389
SPAT
Visit based on need for special support
1.9
6.7
95
507
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.3
6.7
32
97
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
4.0
6.7
25
62
Z29
ICPC
Social problem NOS
3.4
6.7
30
87
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
3.2
6.7
33
103
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
10.7
6.7
12
11
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.9
6.7
38
129
N06AX16
ATC
venlafaxine; oral
2.1
6.7
75
367
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.5
6.7
29
82
N88
ICPC
Epilepsy
6.6
6.6
16
24
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
6.6
6.6
16
24
H52.3
ICD-10 Finland
Anisometropia and aniseikonia
9.1
6.6
13
14
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.3
6.6
23
53
WX402
NOMESCO Finland
General anaesthesia
1.8
6.6
128
759
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
4.9
6.6
20
40
KAY60
NOMESCO Finland
NA
0.0
6.6
*
157
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
22.0
6.6
9
*
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
22.0
6.6
9
*
G81.1
ICD-10 Finland
Spastic hemiplegia
22.0
6.6
9
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
22.0
6.6
9
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.6
6.6
28
78
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.1
6.5
34
110
K59.0
ICD-10 Finland
Constipation
2.7
6.5
43
162
A41.9
ICD-10 Finland
Sepsis, unspecified
3.4
6.5
30
89
XX4BW
NOMESCO Finland
NA
7.6
6.5
14
18
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
6.5
62
282
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
6.4
87
456
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.4
6.4
18
33
SPAT1097
SPAT
Recording of ECG
2.8
6.4
39
140
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
4.5
6.4
21
46
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
9.8
6.4
12
12
H13
ICPC
Plugged feeling ear
2.0
6.3
78
396
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
14.0
6.3
10
7
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.6
6.3
26
71
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.2
6.2
22
52
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.2
182
1209
SPAT1321
SPAT
Health examination of person liable for military service
0.5
6.2
63
1066
SPAT1240
SPAT
Therapeutic discussion
1.8
6.2
116
679
F80.3
ICD-10 Finland
Acquired aphasia with epilepsy [Landau-Kleffner]
+∞
6.2
6
*
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
+∞
6.2
6
*
H50.2
ICD-10 Finland
Vertical strabismus
10.8
6.2
11
10
199
Kela drug reimbursment
Rufinamide
17.6
6.2
9
5
F20.8
ICD-10 Finland
Other schizophrenia
17.6
6.2
9
5
G91.0
ICD-10 Finland
Communicating hydrocephalus
17.6
6.2
9
5
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
5.1
6.1
18
35
AA10D
NOMESCO Finland
NA
26.0
6.1
8
*
RS231
NOMESCO Finland
NA
26.0
6.1
8
*
S18
ICPC
Laceration/cut
1.6
6.1
202
1387
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
6.1
30
94
RS120
NOMESCO Finland
NA
6.9
6.1
14
20
EMB30
NOMESCO Finland
Adenotomy
1.7
6.0
121
723
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.8
6.0
37
134
SPAT1307
SPAT
Psychosocial counselling and guidance
1.8
6.0
110
641
TJD20
NOMESCO Finland
Change of gastrostomy tube
6.1
6.0
15
24
C07AB02
ATC
metoprolol; systemic
2.9
6.0
35
122
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
55
8
68.01
47.13
1.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
222
926
2.65
31.13
2.9
2.4
u/l
266.8
406.9
0.79
217
895
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
422
2440
2.17
27.28
14.0
11.5
mmol/l
1.2
1.2
1.46
410
2310
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
436
2572
2.14
26.55
12.5
10.7
mmol/l
1.2
1.2
0.55
403
2337
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
389
2204
2.15
26.20
3.8
3.2
nmol/l
66.8
68.0
0.40
376
2089
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
520
3376
2.06
23.40
6.8
5.9
u/l
118.8
106.2
2.87
486
3182
(3015377) Calcium [Moles/volume] in Serum or Plasma
256
1291
2.19
22.54
2.5
2.9
mmol/l
2.4
2.4
0.59
237
1176
(3019550) Sodium [Moles/volume] in Serum or Plasma
739
5562
2.47
21.85
16.9
10.9
mmol/l
139.7
139.5
1.96
721
5375
(3023103) Potassium [Moles/volume] in Serum or Plasma
738
5572
2.43
21.27
16.7
10.9
mmol/l
3.9
3.9
1.34
716
5358
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
694
5132
2.22
20.58
4.6
3.8
mu/l
2.0
1.9
2.07
654
4834
(3014111) Lactate [Moles/volume] in Serum or Plasma
127
507
2.56
18.80
11.7
15.1
mmol/l
1.6
1.3
1.31
112
465
(3024561) Albumin [Mass/volume] in Serum or Plasma
304
1757
1.93
17.71
5.8
7.9
g/l
38.3
38.4
0.17
290
1670
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
616
4469
1.94
17.55
4.2
3.4
pmol/l
14.4
14.5
0.44
574
4056
(3003458) Phosphate [Moles/volume] in Serum or Plasma
209
1074
2.06
16.91
10.0
10.7
mmol/l
1.3
1.3
1.52
201
1023
(3018418) pH of Serum or Plasma
213
1109
2.04
16.59
4.9
4.0
ph
7.4
7.4
0.66
48
189
(3013826) Glucose [Moles/volume] in Serum or Plasma
462
3095
1.82
16.54
8.1
6.8
mmol/l
6.0
6.1
0.91
435
2832
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
761
6030
2.28
15.95
10.3
8.2
u/l
30.8
27.5
2.52
742
5830
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
339
2084
1.83
15.93
8.4
7.4
umol/l
18.2
18.5
0.05
315
1916
(3049233) Organic acids panel - Urine
20
21
9.04
15.65
1.2
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
226
1240
1.94
14.98
5.6
4.3
inr
1.1
1.1
0.13
67
371
(3044889) 12 lead EKG panel
379
2446
1.78
14.88
2.7
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
250
1433
1.87
14.43
4.8
4.6
mmol/l
8.5
8.8
0.25
234
1321
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
199
1059
1.97
14.36
12.5
8.6
mmol/l
0.8
0.9
0.13
144
758
(1616796) Gas panel - Central venous blood
45
115
3.78
14.23
5.1
6.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
545
3933
1.76
14.20
3.8
2.3
mmol/l
5.7
5.4
3.57
506
3619
(3009343) pH of Capillary blood
199
1064
1.96
14.14
12.6
8.6
ph
7.4
7.4
0.28
13
42
(3023183) Ammonium ion [Moles/volume] in Plasma
57
174
3.19
13.78
3.9
3.7
umol/l
35.4
33.3
0.30
51
156
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
314
1960
1.76
13.52
5.5
4.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
26
45
5.51
13.16
2.8
2.8
—
—
—
0
0
(3013512) EKG study
145
714
2.07
12.89
3.2
2.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
108
474
2.28
12.82
7.2
6.0
ng/l
838.8
1080.7
0.25
90
373
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
489
3484
1.69
12.73
4.4
3.1
mmol/mol
36.5
36.3
0.20
455
3300
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
80
308
2.56
12.66
5.5
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
204
1149
1.85
12.19
4.2
3.1
mosm/kgh2o
563.7
596.1
0.90
177
995
(3012095) Magnesium [Moles/volume] in Serum or Plasma
149
757
2.00
12.11
11.1
11.2
mmol/l
0.8
0.8
0.21
144
726
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
20
29
6.54
12.02
2.3
2.8
umol/l
21.4
14.2
1.16
20
29
(3000991) Gas panel - Venous blood
188
1039
1.87
11.89
13.0
10.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
203
1154
1.83
11.72
7.7
9.6
mmol/l
1.3
1.2
0.02
158
922
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
275
1717
1.71
11.46
4.3
4.5
u/l
34.9
33.3
0.18
265
1624
(3010421) pH of Blood
42
119
3.40
11.44
6.5
5.9
ph
7.4
7.4
0.10
35
104
(3000850) Epithelial cells [#/volume] in Urine
205
1177
1.81
11.43
4.4
3.2
e6/l
9.5
6.3
1.34
176
1030
(40761535) Cells panel - Urine sediment
65
239
2.65
11.28
3.5
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
287
1823
1.69
11.17
5.6
4.0
e6/l
25.0
51.6
0.75
222
1359
(3015235) Bicarbonate [Moles/volume] in Capillary blood
54
181
2.89
11.14
6.4
11.2
mmol/l
22.9
23.4
0.56
54
166
(3018095) Leukocytes [#/volume] in Urine
331
2190
1.65
10.97
6.6
4.6
e6/l
76.6
59.8
0.24
234
1427
(3019309) Folate [Moles/volume] in Red Blood Cells
83
350
2.33
10.79
1.5
1.6
nmol/l
1091.7
1083.9
0.03
73
267
(3022217) INR in Platelet poor plasma by Coagulation assay
56
195
2.79
10.78
4.1
7.2
inr
1.2
1.1
0.46
13
43
(3036481) Cortisol [Moles/volume] in Serum or Plasma
134
686
1.96
10.59
3.0
2.7
nmol/l
325.4
351.0
0.85
126
653
(3026008) Bacteria identified in Urine by Culture
209
1234
1.76
10.50
3.4
2.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
42
127
3.18
10.34
2.1
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
108
518
2.07
10.22
14.9
18.7
mg/l
1.1
1.0
0.99
108
511
(3030467) Casts [#/volume] in Urine by Automated count
265
1696
1.65
9.79
5.7
3.8
e6/l
0.1
0.2
1.90
207
1243
(3021960) Folate [Moles/volume] in Serum or Plasma
130
681
1.91
9.57
1.7
1.3
nmol/l
17.4
18.9
0.67
119
604
(3033658) Prothrombin time (PT) actual/Normal
244
1546
1.65
9.31
5.5
7.2
%
88.7
87.5
0.35
239
1528
(3032641) Amino acids panel - Urine
15
21
6.74
9.27
1.0
1.3
—
—
—
0
0
(3012787) Ethosuximide [Moles/volume] in Serum or Plasma
9
0
+∞
9.13
4.1
0.0
umol/l
334.0
—
—
9
0
(36304419) Bacteria [Presence] in Urine
264
1714
1.62
9.10
5.6
3.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
70
297
2.30
8.98
6.7
8.5
g/l
0.3
0.4
0.20
42
234
(3022313) Gas panel - Capillary blood
164
943
1.76
8.91
13.0
8.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
163
940
1.75
8.76
3.1
2.0
ng/l
29.4
30.9
0.04
82
328
(3012501) Base excess in Blood by calculation
35
105
3.19
8.75
6.9
6.5
mmol/l
2.2
1.8
0.31
22
56
(3003396) Base excess in Arterial blood by calculation
71
308
2.25
8.65
15.8
15.4
mmol/l
-0.1
0.3
0.34
53
249
(3021589) Normoblasts [#/volume] in Blood
458
3398
1.53
8.64
10.9
10.2
e9/l
0.0
0.0
0.42
369
2595
(3006315) Basophils [#/volume] in Blood
480
3601
1.53
8.57
9.6
8.7
e9/l
0.0
0.0
0.09
415
3015
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
165
965
1.73
8.42
13.2
7.8
mmol/l
23.9
24.0
0.28
165
959
(40767503) Oxygen content in Capillary blood by calculation
34
103
3.15
8.38
3.1
3.2
%
17.7
18.3
0.33
20
62
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
574
0.25
8.34
1.4
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
489
3698
1.52
8.30
10.4
9.4
e9/l
0.2
0.2
0.21
426
3167
(3001604) Monocytes [#/volume] in Blood
478
3600
1.51
8.25
9.6
8.7
e9/l
0.6
0.6
1.75
413
3016
(40758558) Short blood count panel - Blood
293
1988
1.56
8.22
9.3
8.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
112
588
1.88
8.16
3.3
4.0
mg/l
807.0
117.9
0.62
88
452
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
196
1213
1.65
8.06
1.6
1.5
pmol/l
99.3
99.3
0.00
110
634
(4034850)
32
99
3.08
7.63
13.7
5.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
111
597
1.84
7.49
4.3
4.8
mg/mmol
12.2
38.4
0.54
86
460
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
111
598
1.83
7.45
3.3
4.7
g/l
0.2
0.2
0.40
104
573
(3014576) Chloride [Moles/volume] in Serum or Plasma
97
501
1.90
7.42
7.5
12.2
mmol/l
105.5
105.2
0.24
97
492
(3019225) pH of Specimen
60
259
2.24
7.41
3.6
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
737
0.37
7.38
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
174
1070
1.64
7.28
4.6
3.3
e6/l
0.9
0.7
0.53
111
582
(3028707) Methadone [Presence] in Urine by Screen method
85
424
1.96
7.20
4.3
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
674
6863
0.63
7.10
3.5
3.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
43
164
2.51
6.99
1.6
2.0
ug/l
13.0
6.8
0.59
36
137
(3009214) Lutropin [Units/volume] in Serum or Plasma
94
493
1.87
6.86
2.5
2.1
u/l
6.1
5.8
0.18
68
327
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
192
1229
1.58
6.77
3.0
2.8
u/l
53.0
55.9
0.47
180
1140
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
172
1073
1.61
6.76
4.7
3.5
e6/l
5.1
2.1
2.04
111
591
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
157
959
1.64
6.71
2.6
1.6
%
1.7
1.4
1.37
146
877
(3013650) Neutrophils [#/volume] in Blood by Automated count
506
3947
1.45
6.71
14.9
10.6
e9/l
3.8
3.6
1.70
434
3305
(3011397) Hemoglobin [Presence] in Urine by Test strip
213
1403
1.54
6.61
4.0
3.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
428
0.23
6.56
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
126
732
1.70
6.51
2.0
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
44
176
2.40
6.49
3.2
4.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
204
1336
1.55
6.49
4.1
3.3
estimate
0.0
0.0
0.45
70
492
(4198724)
32
110
2.77
6.39
3.9
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
364
2688
1.44
6.36
8.2
9.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
91
486
1.83
6.28
1.6
1.5
pmol/l
434.6
15193196.8
0.50
83
441
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
99
543
1.78
6.26
2.0
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
66
317
2.01
6.24
2.8
2.0
%
30.2
31.4
0.44
48
237
(3015736) pH of Urine
303
2168
1.46
6.23
4.2
3.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
33
117
2.69
6.22
5.8
7.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
50
221
2.17
5.87
2.3
3.1
ml/min/173m2
82.5
92.4
0.53
17
68
(3023368) Bacteria identified in Blood by Culture
163
1037
1.57
5.85
3.7
4.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
480
3764
1.41
5.82
9.6
8.5
e9/l
2.3
2.3
0.76
417
3249
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
97
542
1.75
5.76
1.9
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
198
1325
1.50
5.62
3.0
2.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
438
3410
1.39
5.37
9.0
8.9
%
0.6
0.6
1.25
423
3266
(3017446) Testosterone [Moles/volume] in Serum or Plasma
92
517
1.73
5.36
2.5
2.2
nmol/l
8.7
11.9
2.81
77
434
(3044640) Blood type and Crossmatch panel - Blood
229
1598
1.45
5.23
3.1
2.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
91
515
1.72
5.17
1.5
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
754
6485
1.57
5.17
12.9
7.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
47
215
2.09
5.09
21.8
17.7
%
93.8
95.5
0.65
47
215
(3035637) Corticotropin [Mass/volume] in Plasma
46
209
2.11
5.07
2.0
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
186
1255
1.48
5.03
4.1
3.0
kg/l
1.0
1.0
0.14
21
199
(3021440) Promyelocytes/100 leukocytes in Blood
70
370
1.83
5.02
6.1
5.7
%
0.2
0.1
0.51
25
111
(3019060) Gas panel - Arterial blood
30
114
2.50
4.98
3.9
9.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
44
198
2.12
4.98
22.2
18.2
mmol/l
23.6
24.2
0.59
44
193
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
188
2.13
4.82
21.7
19.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
494
3963
1.36
4.82
9.7
6.4
ml/min/173m2
113.2
109.5
3.16
370
2802
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
514
4157
1.36
4.72
3.8
2.6
mmol/l
2.7
2.7
0.50
485
3916
(3019832) Treponema pallidum Ab [Presence] in Serum
122
1628
0.65
4.68
1.9
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
446
3532
1.35
4.67
9.1
8.9
%
8.3
8.3
0.02
431
3380
(3006504) Eosinophils/100 leukocytes in Blood
442
3498
1.35
4.64
9.0
8.8
%
3.0
3.2
0.81
428
3340
(3007853) Bacteria identified in Skin by Aerobe culture
124
781
1.56
4.62
2.0
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
82
467
1.70
4.57
1.8
2.2
mmol/l
2.4
2.4
0.71
66
394
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
23
4.49
4.53
2.4
2.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
77
432
1.72
4.53
2.0
1.7
mu/l
434.6
317.7
1.94
69
388
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
516
4193
1.35
4.49
3.7
2.7
mmol/l
4.3
4.4
4.09
492
3994
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
509
4129
1.35
4.47
3.6
2.6
mmol/l
1.2
1.4
18.19
479
3913
(3017181) Myelocytes/100 leukocytes in Blood
71
391
1.75
4.46
6.3
5.6
%
1.3
0.6
0.63
25
121
(46235355) HIV 1 and 2 tests - Meaningful Use set
207
2472
0.71
4.34
2.4
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
114
715
1.56
4.33
6.7
6.5
%
1.4
1.4
0.28
109
685
(3025159) Blasts/100 leukocytes in Blood
66
363
1.75
4.18
6.2
5.8
%
0.0
0.0
0.74
21
100
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
101
2.44
4.16
9.0
22.7
u/ml
0.3
0.3
0.08
13
68
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
431
0.40
4.10
1.3
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
60
323
1.78
4.09
1.9
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
51
814
0.56
4.05
1.3
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
19
64
2.80
4.00
1.2
1.1
promille
1.6
1.3
—
10
50
(3031040) Bacteria [#/volume] in Urine by Automated count
440
3535
1.32
3.92
6.2
3.6
e6/l
296.0
154.5
—
9
37
(3023323) Follitropin [Units/volume] in Serum or Plasma
77
451
1.65
3.89
2.5
2.1
iu/l
6.7
7.5
0.33
56
302
(3020891) Body temperature
28
117
2.27
3.84
3.4
7.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
115
1495
0.67
3.81
2.5
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
112
723
1.51
3.73
3.3
3.0
g/l
2.6
2.6
0.33
107
691
(3002179) Metamyelocytes/100 leukocytes in Blood
64
362
1.70
3.69
4.9
5.0
%
1.0
0.4
0.74
21
82
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
51
787
0.58
3.59
1.4
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
99
1310
0.67
3.57
2.5
2.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
27
115
2.22
3.56
6.3
8.4
g/mol
61.8
559.8
0.65
22
108
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
147
1011
1.42
3.54
1.7
1.8
mmol/l
1.5
1.3
1.08
132
930
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
159
1919
0.72
3.43
1.8
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
479
3936
1.29
3.42
3.5
2.5
mmol/l
1.3
1.1
3.82
453
3744
(3035350) Ketones [Presence] in Urine by Test strip
342
2691
1.30
3.41
4.4
3.2
estimate
0.0
0.0
0.00
67
483
(3022948) Iron [Moles/volume] in Serum or Plasma
117
778
1.46
3.38
3.3
3.1
umol/l
13.3
14.4
0.80
111
748
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
34
3.32
3.35
3.9
3.6
umol/l
184.4
221.5
—
5
16
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
267
1.75
3.25
1.9
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
343
2713
1.29
3.25
4.3
3.2
estimate
0.0
0.0
0.00
67
499
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
7
10
6.56
3.19
4.4
12.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
831
7448
1.67
3.16
23.8
14.4
e9/l
7.2
6.8
2.46
801
7131
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
145
1015
1.39
3.16
3.4
3.9
mg/l
1.2
1.5
0.38
112
681
(3051651) Icteric interference index of Serum or Plasma
20
79
2.39
3.14
3.9
5.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
106
702
1.46
3.13
4.6
6.4
umol/l
4.9
6.8
1.57
91
579
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
17
62
2.58
3.13
1.2
1.1
mg/l
271.3
289.9
0.35
17
55
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
314
1.67
3.10
3.1
2.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
830
7441
1.66
3.09
23.6
14.3
pg
29.0
29.2
2.02
819
7340
(3024731) MCV [Entitic volume]
830
7442
1.65
3.08
23.6
14.3
fl
86.6
86.8
0.36
819
7339
(3007461) Platelets [#/volume] in Blood
829
7431
1.65
3.07
23.8
14.4
e9/l
270.6
264.9
1.60
801
7122
(3026361) Erythrocytes [#/volume] in Blood
830
7443
1.65
3.06
23.7
14.3
e12/l
4.7
4.7
0.38
797
7119
(3002030) Lymphocytes/100 leukocytes in Blood
452
3720
1.27
3.05
9.1
8.5
%
33.6
34.6
1.00
437
3571
(4024509)
9
19
4.44
3.03
2.1
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
366
0.45
3.02
1.5
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
83
1101
0.67
3.02
2.2
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
87
2.28
2.98
3.9
5.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
830
7449
1.64
2.97
24.8
14.6
g/l
136.1
136.5
0.27
821
7344
(3018010) Neutrophils/100 leukocytes in Blood
443
3649
1.26
2.92
8.9
8.4
%
51.5
50.3
1.16
428
3505
(3021601) Nitrite [Presence] in Urine by Test strip
337
2688
1.27
2.91
5.8
4.6
estimate
0.0
0.0
0.00
71
515
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
73
457
1.53
2.84
5.5
8.8
%
94.5
92.7
0.28
73
451
(3009542) Hematocrit [Volume Fraction] of Blood
685
6733
0.76
2.78
19.3
12.5
%
39.0
40.3
4.25
553
5978
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
435
3589
1.25
2.78
4.7
3.7
u/l
37.1
28.4
3.69
420
3448
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
137
1.93
2.64
4.0
4.4
%
47.9
50.9
0.70
28
137
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
206
1.75
2.61
1.8
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
280
0.42
2.56
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
195
1474
1.30
2.54
2.4
3.2
mg/l
3.1
2.6
2.81
172
1321
(40761536) Microorganisms panel - Urine sediment
73
470
1.49
2.51
4.0
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
38
209
1.72
2.50
1.8
2.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
140
1.89
2.49
1.1
1.4
ug/g
403.5
383.6
0.20
17
66
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
75
487
1.47
2.48
2.2
2.6
u/l
27.2
31.7
0.78
64
395
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
254
1.64
2.43
1.3
1.5
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
7
6.68
2.42
15.2
4.7
umol/l
48.1
46.1
—
5
7
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
135
1.89
2.41
1.5
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
12
42
2.68
2.41
7.3
6.9
mmol/l
1.2
1.2
0.68
12
35
(3002385) Erythrocyte distribution width [Ratio]
691
6059
1.28
2.40
20.8
13.6
%
13.3
13.1
3.57
675
5943
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
17
71
2.25
2.40
2.2
2.6
ug/l
4.7
3.3
0.13
17
61
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
38
212
1.70
2.39
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
38
212
1.70
2.39
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
200
2235
0.78
2.38
2.8
2.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
84
2.13
2.36
1.6
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
32
2.93
2.34
1.3
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
137
1.86
2.32
1.5
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
29
151
1.81
2.30
1.8
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
33
503
0.60
2.27
1.2
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
242
1906
1.25
2.24
3.9
3.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
146
1.81
2.22
1.8
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
80
2.12
2.21
1.2
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
75
500
1.43
2.19
5.5
4.8
e9/l
68.6
63.1
0.60
56
308
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
140
1.82
2.18
1.6
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
20
346
0.53
2.17
1.3
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
23
381
0.55
2.16
1.3
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
57
2.31
2.11
4.1
5.0
mmol/l
3.7
3.9
0.33
14
50
(3042517) Benzodiazepines panel - Urine
8
23
3.26
2.10
3.3
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
450
3798
1.21
2.09
5.6
3.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
40
2.58
2.07
2.1
2.6
pg
32.2
32.0
0.04
11
40
(3004588) Protein electrophoresis panel - Serum or Plasma
15
64
2.20
2.04
1.1
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
77
2.08
2.01
7.6
8.6
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
9
30
2.81
1.97
1.0
1.0
—
19.3
—
0
6
(3042936) Bacteria identified in Isolate by Culture
89
624
1.36
1.96
1.9
2.0
—
—
—
0
0
(3000492) Spirometry study
37
528
0.64
1.96
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
204
1.62
1.91
2.2
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
722
6415
1.26
1.91
14.4
9.8
mg/l
22.0
22.4
0.14
555
4427
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
48
2.34
1.89
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
48
2.34
1.89
1.0
1.0
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
16
73
2.06
1.87
4.3
4.1
%
12.6
2.4
—
7
26
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
9
32
2.63
1.83
2.3
2.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
43
2.40
1.82
1.7
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
136
1.73
1.77
3.2
4.1
e9/l
3.5
3.3
0.23
25
136
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
50
2.25
1.74
1.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
20
102
1.84
1.74
3.4
2.2
mmol/l
1.4
2.1
0.76
13
80
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
44
2.34
1.74
7.5
8.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
17
3.30
1.71
1.7
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
36
219
1.55
1.68
1.8
4.3
e6/l
8.3
7.0
0.07
30
154
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
36
219
1.55
1.68
1.8
4.4
e6/l
105.5
387.5
0.75
31
159
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
318
0.58
1.67
2.4
1.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
39
2.40
1.66
2.3
7.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
291
3034
0.84
1.66
2.0
1.9
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
19
97
1.84
1.65
1.2
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
21
111
1.78
1.64
1.0
1.1
g/l
1.5
1.4
0.38
21
102
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
57
384
1.41
1.62
5.2
6.7
%
164.3
161.3
0.12
57
376
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
192
2075
0.82
1.61
2.7
2.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
13
3.59
1.60
4.0
3.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
40
2.34
1.59
2.3
7.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
459
3947
1.17
1.55
4.2
4.0
mm/h
7.8
7.0
1.21
429
3665
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
29
412
0.64
1.55
1.4
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
14
66
1.99
1.53
1.6
1.6
mu/l
68.5
248.2
0.66
14
60
(3041354) Potassium [Moles/volume] in Venous blood
7
25
2.62
1.51
1.6
1.9
mmol/l
3.9
3.9
—
7
25
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
25
2.62
1.51
3.6
5.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
14
3.34
1.51
3.0
2.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
39
518
0.69
1.50
1.1
1.2
u/ml
3.0
4.2
0.30
15
166
(3006184) Hemoglobin [Mass/volume] in Capillary blood
24
136
1.66
1.50
2.3
2.8
g/l
137.9
139.2
0.10
24
109
(3024928) Oxygen saturation in Venous blood
27
158
1.61
1.50
7.6
19.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
31
189
1.55
1.46
1.4
1.8
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
20
2.80
1.46
1.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
13
61
2.00
1.44
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
199
0.51
1.44
1.5
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
175
1.56
1.43
1.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
128
1424
0.81
1.43
1.6
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
359
0.64
1.42
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
245
0.56
1.41
1.6
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
169
1345
1.21
1.40
7.7
4.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
255
0.58
1.38
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
243
0.57
1.38
1.7
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
19
289
0.60
1.38
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
19
289
0.60
1.38
1.4
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
69
1.90
1.37
1.6
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
177
1.54
1.37
3.0
2.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
26
366
0.65
1.36
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
388
0.66
1.35
2.1
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
26
365
0.65
1.34
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
26
365
0.65
1.34
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
26
365
0.65
1.34
1.3
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
27
163
1.56
1.34
3.9
3.3
e9/l
1.0
1.5
2.00
19
106
(3049717) Cytology report of Urine Cyto stain
8
31
2.41
1.31
1.3
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
69
814
0.77
1.28
1.9
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
91
685
1.26
1.27
5.6
4.4
umol/l
329.3
2329.8
1.31
84
646
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
24
143
1.58
1.27
2.9
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
17
2.75
1.25
1.0
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
111
0.42
1.25
1.8
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
23
2.44
1.25
1.7
2.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
107
1.67
1.24
10.0
25.0
%
11.5
11.6
0.08
19
107
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
170
1815
0.84
1.24
1.9
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
37
245
1.42
1.21
1.7
1.7
ug/l
0.8
0.9
0.80
31
224
(44790047)
26
160
1.53
1.21
2.0
2.1
—
—
—
0
0
(44790049)
26
160
1.53
1.21
2.0
2.1
—
—
—
0
0
(44790048)
26
160
1.53
1.21
2.0
2.1
—
—
—
0
0
(44806118)
26
160
1.53
1.21
2.0
2.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
123
1.60
1.19
1.7
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
78
581
1.27
1.19
1.3
1.3
iu/ml
71.2
118.8
0.57
21
192
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
299
2528
1.15
1.19
1.6
1.8
u/ml
1.0
3.1
3.59
64
494
(3035285) Chloride [Moles/volume] in Venous blood
6
24
2.34
1.19
1.7
2.0
mmol/l
105.2
106.5
—
6
24
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
272
2285
1.16
1.18
4.3
4.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
32
0.00
1.16
0.0
1.2
—
6.0
—
0
5
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
11
53
1.94
1.16
6.9
6.9
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
11
53
1.94
1.16
5.9
6.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
47
575
0.75
1.15
1.1
1.3
u/ml
5.0
2.3
0.42
26
363
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
296
0.65
1.13
1.3
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
425
0.71
1.12
1.2
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
25
156
1.51
1.11
3.8
3.3
%
12.2
9.9
0.43
20
144
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
29
2.26
1.10
1.4
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
43
528
0.75
1.09
1.1
1.2
u/ml
0.3
1.1
2.60
22
368
(3020393) Adenovirus Ag [Presence] in Stool
19
112
1.59
1.07
2.1
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
44
537
0.75
1.07
1.1
1.2
u/ml
4.7
7.2
0.50
25
403
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
62
1.81
1.05
10.5
9.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
450
0.73
1.03
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
100
781
1.22
1.03
4.1
2.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
91
704
1.23
1.03
3.7
3.3
ng/l
3223.8
1018.8
0.55
51
363
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
18
106
1.59
1.02
2.9
4.9
umol/l
25.2
24.4
0.19
18
106
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
44
1.91
1.02
1.1
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
13
70
1.74
1.01
1.5
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
70
1.74
1.01
2.5
2.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
24
152
1.48
1.01
3.5
3.3
e6/l
250.6
328.9
0.46
18
97
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
21
2.22
1.00
1.8
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
71
1.71
0.97
1.4
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
57
1.81
0.96
2.8
2.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
11
173
0.59
0.96
1.4
1.2
u/ml
0.5
2.8
—
5
44
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
83
643
1.22
0.94
3.2
2.6
u/l
14623.3
4725.1
0.52
20
241
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
7
35
1.87
0.92
1.6
2.5
ug/min
8.7
204.7
—
7
29
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
148
1.46
0.91
1.9
1.9
iu/l
8.2
4.6
—
8
54
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
66
1.70
0.88
1.2
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
27
181
1.40
0.87
1.3
1.1
iu/ml
93.2
231.8
—
6
56
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
167
0.61
0.85
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
29
1.93
0.84
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
254
0.69
0.83
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
124
1311
0.86
0.82
2.8
3.4
ug/g
96.5
110.5
0.21
94
1046
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
152
1.42
0.81
1.3
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
30
1.87
0.81
4.0
6.0
ug/l
87.8
214.1
—
6
30
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.79
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
84
665
1.19
0.79
4.5
3.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
114
1.48
0.78
1.7
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
25
0.00
0.78
0.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
274
2362
1.12
0.78
1.7
1.6
g/l
1.7
1.7
0.12
148
1279
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
154
1.40
0.76
3.9
3.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
49
1.72
0.76
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
49
1.72
0.76
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
49
1.72
0.76
1.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
51
1.65
0.74
1.6
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
51
1.65
0.74
1.6
1.6
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
12
70
1.60
0.73
3.7
5.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
52
1.62
0.72
4.3
3.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
52
1.62
0.72
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
29
205
1.33
0.71
1.8
4.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
24
1.94
0.71
1.8
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
64
1.61
0.68
1.5
1.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
39
1.68
0.68
2.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
39
1.68
0.68
2.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
39
1.68
0.68
2.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
39
1.68
0.68
1.3
2.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
88
0.53
0.67
1.4
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
72
1.56
0.67
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
40
1.63
0.67
1.3
1.2
nmol/l
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
26
1.79
0.66
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
333
0.78
0.63
1.6
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
28
1.67
0.61
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
18
0.00
0.60
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
20
0.00
0.60
0.0
2.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
59
643
0.84
0.60
1.3
1.2
u/ml
1.2
7.6
2.73
21
217
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
50
1.49
0.57
1.4
1.2
—
—
—
0
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
6
33
1.70
0.57
2.7
1.7
mg/l
0.4
1.4
—
6
26
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
6
33
1.70
0.57
2.7
1.7
mg/l
1.7
4.0
—
6
28
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
33
1.70
0.57
1.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.70
0.57
1.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.70
0.57
1.0
1.8
—
—
—
0
0
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
6
33
1.70
0.57
2.7
1.7
mg/l
1.2
7.1
—
6
26
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
6
33
1.70
0.57
2.7
1.7
mg/l
2.5
3.6
—
6
27
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
33
1.70
0.57
1.0
1.2
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
6
33
1.70
0.57
2.7
1.7
mg/l
0.8
1.8
—
6
26
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
64
689
0.85
0.57
1.3
1.2
iu/ml
39.3
14.8
—
9
155
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
245
0.75
0.57
1.5
1.6
iu/ml
0.0
0.1
—
7
64
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
245
0.75
0.57
1.6
1.3
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
6
34
1.65
0.56
2.7
1.7
mg/l
1.4
1.5
—
6
28
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
68
1.51
0.55
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
138
0.67
0.55
2.1
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
35
1.60
0.55
1.0
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
108
1.39
0.54
1.4
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
57
455
1.18
0.53
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
38
425
0.82
0.52
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
92
0.60
0.52
1.3
2.9
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
12
77
1.46
0.52
2.0
2.7
mmol/l
33.6
33.6
0.00
12
77
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
59
1.42
0.52
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
59
1.42
0.52
1.4
1.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
27
312
0.80
0.50
1.1
1.1
—
9.0
—
0
14
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
44
1.48
0.47
1.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
111
1.35
0.47
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
206
0.76
0.46
1.6
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
79
0.59
0.45
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
43
342
1.18
0.44
1.6
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
29
1.61
0.43
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
89
1.36
0.42
1.7
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
8.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
14
0.00
0.41
0.0
1.4
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
3.7
—
0.4
—
0
14
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
283
0.82
0.41
5.4
4.3
umol/l
12.5
8.9
0.61
20
239
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
31
1.50
0.41
1.8
1.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
123
1.29
0.40
2.7
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
70
725
0.89
0.39
1.7
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
356
1.16
0.38
3.6
2.0
e9/l
4.4
4.2
0.18
38
321
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
34
1.37
0.37
1.6
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
34
369
0.85
0.37
1.4
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
21
238
0.82
0.36
1.3
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
113
0.74
0.35
1.1
1.5
—
242.9
—
0
7
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
113
0.74
0.35
1.1
1.5
—
193.3
—
0
27
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
75
0.62
0.35
5.6
3.2
u/ml
7.0
32.1
—
5
63
(3045142) Bone marrow Pathology biopsy report
5
75
0.62
0.35
2.0
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
197
0.80
0.35
1.0
1.1
u/ml
6.4
6.3
—
5
74
(3022621) pH of Urine by Test strip
35
280
1.17
0.35
2.4
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
40
1.40
0.35
1.2
1.6
—
—
—
0
0
(4062490)
15
109
1.29
0.35
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
13
155
0.78
0.34
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
82
0.68
0.33
1.5
1.1
—
—
—
0
0
(4010399)
35
282
1.16
0.33
1.5
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
21
161
1.22
0.33
1.8
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
153
1.22
0.32
2.0
5.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
108
935
1.09
0.31
3.5
2.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
56
469
1.12
0.31
2.4
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
162
1.21
0.31
1.9
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
128
1.24
0.31
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
92
0.71
0.31
1.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
53
1.23
0.29
1.6
3.5
ug/l
20.8
32.7
—
7
48
(3005322) IgE [Units/volume] in Serum or Plasma
81
696
1.09
0.29
1.4
1.4
u/ml
144.4
360.4
3.14
75
658
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
58
1.29
0.28
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
31
329
0.87
0.27
1.1
1.1
u/ml
13.2
8.5
0.46
16
182
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
60
1.24
0.27
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
71
1.31
0.27
1.7
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
61
1.22
0.27
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
88
1.27
0.27
1.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
69
0.67
0.26
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
69
0.67
0.26
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
70
0.66
0.26
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.66
0.26
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.66
0.26
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.66
0.26
1.0
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
97
1.25
0.26
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
140
1.20
0.25
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
22
175
1.17
0.25
1.2
1.2
—
—
—
0
0
(4027681)
9
70
1.20
0.25
1.4
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
13
98
1.24
0.24
1.1
1.2
%
107.7
113.9
0.19
13
93
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
22
176
1.17
0.24
1.2
1.1
iu/ml
3.4
7.9
—
7
24
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
37
383
0.89
0.23
1.5
1.3
miu/ml
89.0
247.4
—
5
185
(3004616) Nuclear Ab [Presence] in Serum
5
35
1.33
0.23
1.8
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
52
443
1.10
0.23
2.0
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
36
1.29
0.23
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
36
1.29
0.23
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
36
1.29
0.23
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
36
1.29
0.23
1.0
1.1
—
—
—
0
0
(4094501)
5
36
1.29
0.23
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
82
814
0.93
0.22
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
66
571
1.08
0.22
1.5
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(4038314)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.8
—
2.5
—
0
11
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
80.6
—
0
11
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
40
1.16
0.21
1.2
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
40
1.16
0.21
1.6
1.7
—
1448620.0
—
0
5
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.1
—
12.4
—
0
12
(3052592) Norovirus Ag [Presence] in Stool
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
44
1.27
0.20
1.2
1.2
iu/ml
134.2
236.8
—
6
44
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
13
0.00
0.20
0.0
3.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
109
1.20
0.20
1.4
1.4
u/ml
4.2
5.4
—
9
53
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
104
0.80
0.20
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
105
0.80
0.20
1.3
1.3
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
23
188
1.14
0.20
1.0
1.0
mmol/l
-0.1
-2.7
—
6
38
(3006598) pH of Arterial cord blood
23
188
1.14
0.20
1.0
1.0
—
—
—
0
0
(44813793)
13
101
1.20
0.19
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
49
1.14
0.19
1.2
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
28
289
0.90
0.18
1.1
1.1
u/ml
2.3
0.4
0.38
11
126
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
30
252
1.11
0.18
1.8
1.5
g/l
0.2
0.2
0.42
30
240
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
58
1.12
0.17
1.0
1.1
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
5
61
0.76
0.17
1.0
1.2
—
3.1
—
0
35
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
63
0.74
0.17
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
108
1050
0.95
0.17
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
65
0.71
0.17
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
65
0.71
0.17
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
65
0.71
0.17
1.4
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
161
0.86
0.16
1.2
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
64
1.16
0.16
1.1
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
209
1.12
0.16
1.4
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
71
0.78
0.15
1.0
2.0
—
—
—
0
0
(4268621)
9
72
1.16
0.15
2.4
2.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
139
1.14
0.15
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
75
1.12
0.15
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
77
1.09
0.14
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
202
1.11
0.14
1.4
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
131
1.14
0.14
2.1
4.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
34
293
1.08
0.13
2.2
1.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
91
813
1.05
0.13
1.5
1.5
titre
527.3
511.9
0.02
11
114
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
1199
1.04
0.13
1.9
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
89
1.15
0.10
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
206
1.09
0.10
1.4
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
25
216
1.08
0.09
1.1
1.4
u/ml
3.1
3.8
0.09
19
153
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
44
1.06
0.09
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
45
1.03
0.09
1.0
1.1
miu/ml
1508.6
1594.1
—
5
45
(3041096) Erythrocytes [Presence] in Urine by Automated
158
1439
1.03
0.09
3.7
2.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
235
1.07
0.09
1.3
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
345
1.05
0.08
2.4
2.0
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
5
59
0.79
0.08
1.0
1.2
—
7.9
—
0
33
(3000475) Leukocytes [#/volume] in Synovial fluid
5
60
0.77
0.08
1.2
1.8
e6/l
4989.0
12062.9
—
5
43
(3023430) Cat dander IgE Ab [Units/volume] in Serum
31
305
0.94
0.08
1.1
1.1
u/ml
9.9
10.8
0.06
14
186
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
7
62
1.05
0.08
1.0
1.7
—
1.2
—
0
12
(4306422)
11
91
1.13
0.08
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
63
1.03
0.08
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
70
0.80
0.07
6.3
3.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
70
0.80
0.07
6.3
3.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
328
3021
1.02
0.07
3.3
3.1
ug/l
63.9
61.4
0.18
307
2864
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
82
1.02
0.07
1.4
2.3
mg/l
11.8
8.9
—
9
77
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
8
85
0.87
0.07
1.0
1.0
g/l
171.5
164.5
—
8
85
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
110
1.10
0.06
1.4
1.4
u/ml
2.5
8.4
—
6
45
(4035726)
35
311
1.05
0.06
1.7
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
45
435
0.96
0.06
2.1
1.8
u/ml
204.0
166.4
0.55
28
218
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
122
0.91
0.05
2.3
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
233
2191
0.99
0.05
1.5
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
148
1.07
0.05
1.9
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
40
385
0.97
0.05
1.5
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
19
187
0.94
0.04
1.3
1.7
—
12.1
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
296
1.04
0.04
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
139
0.94
0.03
2.6
2.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
110
1010
1.02
0.03
3.7
2.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
14
138
0.94
0.02
1.6
2.2
u/ml
28.7
37.6
0.31
14
133
(3028300) Cannabinoids [Presence] in Urine
110
1012
1.01
0.02
3.8
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
109
1003
1.01
0.02
3.7
2.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
86
1.08
0.02
1.1
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
86
1.08
0.02
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
123
1.06
0.02
2.1
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
106
996
0.99
0.02
3.8
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
15
146
0.96
0.01
1.5
1.9
u/l
44.3
39.0
0.51
15
137
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
12
106
1.05
0.01
3.1
3.4
ug/l
1.9
2.1
—
6
57
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
47
443
0.99
0.00
2.1
1.8
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
15
145
0.96
0.00
1.2
1.4
u/ml
89.4
13.7
—
9
118
(3014148) Varicella zoster virus Ab [Titer] in Serum
24
218
1.03
0.00
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
88
1.06
0.00
1.4
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
131
0.99
0.00
1.3
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
46
426
1.01
0.00
1.4
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
104
0.98
0.00
1.1
1.3
—
1.5
—
0
7
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
24
223
1.00
0.00
1.7
1.6
nmol/l
29.4
35.8
1.16
24
217
(3029634) Reagin Ab [Titer] in Serum by VDRL
19
177
1.00
0.00
2.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
152
0.98
0.00
1.9
2.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
105
0.97
0.00
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
159
0.99
0.00
4.6
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
166
1.01
0.00
1.2
1.3
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
2.6
—
0
7
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
48
0.97
0.00
2.0
3.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
48
0.97
0.00
1.2
1.4
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
251.4
—
0
7
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
63
0.89
0.00
1.7
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
13.9
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
57
0.98
0.00
2.0
2.1
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
28.4
—
0
8
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
85
0.99
0.00
1.8
2.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
29.4
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
57
0.98
0.00
1.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
86
0.97
0.00
1.4
1.1
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
5
0.00
0.00
0.0
1.0
—
18.1
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
5
49
0.95
0.00
1.0
1.2
—
0.8
—
0
29
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
8.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
49
0.95
0.00
1.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
64
0.87
0.00
1.5
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
49
0.95
0.00
1.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
50
0.93
0.00
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
66
0.99
0.00
1.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_MIXEDDEV and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MIXEDDEV | 3.661 [2.58, 5.2] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 8685 females with F5_MIXEDDEV died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MIXEDDEV | 2.156 [1.77, 2.62] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 146 out of 19887 males with F5_MIXEDDEV died.
Mortality risk
Mortality risk for people of age
years, who have F5_MIXEDDEV.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.259% | 0.317% |
| 5 | 1.439% | 2.249% |
| 10 | 4.139% | 6.384% |
| 15 | 8.235% | 11.432% |
| 20 | 14.601% | 18.666% |
Relationships between endpoints
↥Index endpoint: F5_MIXEDDEV – Mixed specific developmental disorders
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data